GenAI, or Generative AI, has seen a surge in patenting activity with China leading the way in filing patent applications for ...

Although gene-editing and other techniques can improve the production of microbe-based biologics, AI could push these drugs ...

High-ranking OpenAI employees have met with the FDA multiple times in recent weeks to discuss AI and a project called cderGPT ...

We came across a bullish thesis on ICON Public Limited Company (ICLR) on Substack by DeepValue Capital. In this article, we ...

Advances in AI, genomics, and liquid biopsy are reshaping cancer care, but systemic gaps persist in access and funding, ...

At RFID Journal LIVE!, we bring together the best minds in the industry to explore the intersection of RFID IoT, AI and other ...

Learn about April 2025’s top biotech deals, featuring major collaborations in bispecific antibodies, protein therapies, and ...

South Korea's largest health and pharmaceutical industry trade fair, kicked off Wednesday, bringing together some 750 ...

BMS pledges $40B over five years to boost U.S. R&D, tech innovation, and pharmaceutical manufacturing under CEO Christopher ...

Residents in a vulnerable Memphis neighborhood have reported health issues as Elon Musk's xAI operates numerous gas turbines ...

Asembia’s AXS25 Summit covered a variety of relevant topics in the pharmaceutical industry, from the effects of the new ...

Bristol Myers Squibb (BMS) plans to invest $40bn in the US over the next five years to bolster its research and manufacturing ...